Search Results - "Cazzaniga, Massimiliano"

Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis by Decensi, Andrea, Puntoni, Matteo, Goodwin, Pamela, Cazzaniga, Massimiliano, Gennari, Alessandra, Bonanni, Bernardo, Gandini, Sara

“…Metformin, an insulin-lowering agent, has been associated with decreased cancer risk in epidemiologic studies in diabetic patients. We performed a…”
Get full text

Ovarian Microbiota, Ovarian Cancer and the Underestimated Role of HPV by Cazzaniga, Massimiliano, Cardinali, Marco, Di Pierro, Francesco, Bertuccioli, Alexander

“…In recent years, many studies have highlighted the possible close correlation between human diseases and definite patterns of microbial organisms colonizing…”
Get full text

Gut Microbiota, Metabolic Disorders and Breast Cancer: Could Berberine Turn Out to Be a Transversal Nutraceutical Tool? A Narrative Analysis by Cazzaniga, Massimiliano, Zonzini, Giordano Bruno, Di Pierro, Francesco, Moricoli, Sara, Bertuccioli, Alexander

“…Metabolic disorders, mainly characterized as the marked alteration of the lipid and carbohydrate profile, in addition to the clinical presence of the direct…”
Get full text

Is it Time to Test Metformin in Breast Cancer Clinical Trials? by CAZZANIGA, Massimiliano, BONANNI, Bernardo, GUERRIERI-GONZAGA, Aliana, DECENSI, Andrea

“…Several studies have identified an increased risk of cancer in type 2 diabetic patients and this is in accordance with the hypothesis that increased insulin…”
Get full text

Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial by BONANNI, Bernardo, PUNTONI, Matteo, JOHANSSON, Harriet, ARISTARCO, Valentina, BASSI, Fabio, LUINI, Alberto, LAZZERONI, Matteo, VARRICCHIO, Clara, VIALE, Giuseppe, BRUZZI, Paolo, DECENSI, Arvdrea, CAZZANIGA, Massimiliano, PRUNERI, Giancarlo, SERRANO, Davide, GUERRIERI-GONZAGA, Aliana, GENNARI, Alessandra, STELLA TRABACCA, Maria, GALIMBERTI, Viviana, VERONESI, Paolo

“…Metformin is associated with reduced breast cancer risk in observational studies in patients with diabetes, but clinical evidence for antitumor activity is…”
Get full text

The Potential Role of Probiotics, Especially Butyrate Producers, in the Management of Gastrointestinal Mucositis Induced by Oncologic Chemo-Radiotherapy by Cazzaniga, Massimiliano, Cardinali, Marco, Di Pierro, Francesco, Zonzini, Giordano Bruno, Palazzi, Chiara Maria, Gregoretti, Aurora, Zerbinati, Nicola, Guasti, Luigina, Bertuccioli, Alexander

“…Many clinical studies have now highlighted how the composition of the intestinal microbiota can regulate the effects of many oncological therapies. In…”
Get full text

Influence of the microbiota on the effectiveness and toxicity of oncological therapies, with a focus on chemotherapy by Cazzaniga, Massimiliano, Zonzini, Giordano Bruno, Di Pierro, Francesco, Palazzi, Chiara Maria, Cardinali, Marco, Bertuccioli, Alexander

“…Recent studies have highlighted a possible correlation between microbiota composition and the pathogenesis of various oncological diseases. Also, many…”
Get full text

Lactobacillus crispatus M247: Characteristics of a Precision Probiotic Instrument for Gynecological and Urinary Well-Being by Bertuccioli, Alexander, Cardinali, Marco, Zonzini, Giordano, Cazzaniga, Massimiliano, Di Pierro, Francesco

“…The altered patterns of a microbial population colonizing an organ are increasingly recognized as a relevant item in human disease pathogenesis. The female…”
Get full text

A Controlled, Retrospective, Single-Center Study to Evaluate the Role of a Probiotic Mixture Administered during Pregnancy in Reducing Streptococcus Agalactiae Swab Positivity and the Frequency of Premature Rupture of Amniochorionic Membranes by Arduini, Maurizio, Laurenti, Elena, Cazzaniga, Massimiliano, Bertuccioli, Alexander, Cavecchia, Ilaria, Matera, Mariarosaria, Zerbinati, Nicola, Di Pierro, Francesco

“…Intrapartum antibiotic prophylaxis, considered able to prevent streptococcal transmission from mother to newborn and its severe negative consequences, leads to…”
Get full text

Clostridium butyricum Strain MIYAIRI 588 (CBM588) as a Precision Probiotic Therapy in the Ketogenic Diet: A Possible Application? by Bertuccioli, Alexander, Cardinali, Marco, Zonzini, Giordano, Neri, Marco, Palazzi, Chiara Maria, Gregoretti, Aurora, Cazzaniga, Massimiliano, Di Pierro, Francesco

“…The ketogenic diet has proven to be effective in many recent studies not only as a weight-losing strategy but also as a valuable add-on therapy in medical…”
Get full text

Effect of Bifidobacterium bifidum Supplementation in Newborns Born from Cesarean Section on Atopy, Respiratory Tract Infections, and Dyspeptic Syndromes: A Multicenter, Randomized, and Controlled Clinical Trial by Bellomo, Anna Rita, Rotondi, Giulia, Rago, Prudenza, Bloise, Silvia, Di Ruzza, Luigi, Zingoni, Annamaria, Di Valerio, Susanna, Valzano, Eliana, Di Pierro, Francesco, Cazzaniga, Massimiliano, Bertuccioli, Alexander, Guasti, Luigina, Zerbinati, Nicola, Lubrano, Riccardo

“…Cesarean section is considered a possible trigger of atopy and gut dysbiosis in newborns. Bifidobacteria, and specifically , are thought to play a central role…”
Get full text

Sports-Related Gastrointestinal Disorders: From the Microbiota to the Possible Role of Nutraceuticals, a Narrative Analysis by Bertuccioli, Alexander, Zonzini, Giordano Bruno, Cazzaniga, Massimiliano, Cardinali, Marco, Di Pierro, Francesco, Gregoretti, Aurora, Zerbinati, Nicola, Guasti, Luigina, Matera, Maria Rosaria, Cavecchia, Ilaria, Palazzi, Chiara Maria

“…Intense physical exercise can be related to a significant incidence of gastrointestinal symptoms, with a prevalence documented in the literature above 80%,…”
Get full text

The Anti-Constipation Effect of Bifidobacterium Longum W11 Is Likely Due to a Key Genetic Factor Governing Arabinan Utilization by Di Pierro, Francesco, Zerbinati, Nicola, Cazzaniga, Massimiliano, Bertuccioli, Alexander, Palazzi, Chiara Maria, Cavecchia, Ilaria, Matera, Mariarosaria, Labrini, Edoardo, Sagheddu, Valeria, Soldi, Sara

“…Recent investigations have highlighted, both experimentally and clinically, that probiotic strains equipped with arabinofuranosidase, in particular and , favor…”
Get full text

The Role of Short-Chain Fatty Acids, Particularly Butyrate, in Oncological Immunotherapy with Checkpoint Inhibitors: The Effectiveness of Complementary Treatment with Clostridium butyricum 588 by Cazzaniga, Massimiliano, Cardinali, Marco, Di Pierro, Francesco, Zonzini, Giordano Bruno, Palazzi, Chiara Maria, Gregoretti, Aurora, Zerbinati, Nicola, Guasti, Luigina, Matera, Maria Rosaria, Cavecchia, Ilaria, Bertuccioli, Alexander

“…The discovery of immune checkpoints (CTLA-4, PD-1, and PD-L1) and their impact on the prognosis of oncological diseases have paved the way for the development…”
Get full text

Bifidobacterium breve PRL2020: Antibiotic-Resistant Profile and Genomic Detection of Antibiotic Resistance Determinants by Di Pierro, Francesco, Campedelli, Ilenia, De Marta, Patrick, Fracchetti, Fabio, Del Casale, Antonio, Cavecchia, Ilaria, Matera, Mariarosaria, Cazzaniga, Massimiliano, Bertuccioli, Alexander, Guasti, Luigina, Zerbinati, Nicola

“…Antibiotics are one of the greatest scientific achievements of modern medicine, but excessive use is creating challenges for the future of medicine. Antibiotic…”
Get full text

Effect of L. crispatus M247 Administration on Pregnancy Outcomes in Women Undergoing IVF: A Controlled, Retrospective, Observational, and Open-Label Study by Di Pierro, Francesco, Sinatra, Francesco, Cester, Maddalena, Da Ros, Lucia, Pistolato, Mara, Da Parè, Vania, Fabbro, Laura, Maccari, Daniela, Dotto, Silvia, Sossai, Sara, Fabozzi, Gemma, Bertuccioli, Alexander, Cazzaniga, Massimiliano, Recchia, Martino, Zerbinati, Nicola, Guasti, Luigina, Baffoni, Andrea

“…The aim of our study was to retrospectively evaluate whether the oral administration of L. crispatus (M247) could increase pregnancy and live birth rates in…”
Get full text

Randomized Dose-Ranging Trial of Tamoxifen at Low Doses in Hormone Replacement Therapy Users by DECENSI, Andrea, GANDINI, Sara, MACIS, Debora, LAZZERONI, Matteo, PENOTTI, Mauro, SIRONI, Laura, MORONI, Simona, BIANCO, Vanda, RONDANINA, Gabriella, GJERDE, Jennifer, GUERRIERI-GONZAGA, Aliana, BONANNI, Bernardo, SERRANO, Davide, CAZZANIGA, Massimiliano, PIZZAMIGLIO, Maria, MAFFINI, Fausto, PELOSI, Giuseppe, DALDOSS, Cristina, OMODEI, Umberto, JOHANSSON, Harriet

“…The combination of hormone replacement therapy (HRT) and low-dose tamoxifen may retain the benefits while reducing the risks of either agent. We assessed the…”
Get full text

Randomized Biomarker Trial of Anastrozole or Low-Dose Tamoxifen or Their Combination in Subjects with Breast Intraepithelial Neoplasia by Bonanni, Bernardo, Serrano, Davide, Gandini, Sara, Guerrieri-Gonzaga, Aliana, Johansson, Harriet, Macis, Debora, Cazzaniga, Massimiliano, Luini, Alberto, Cassano, Enrico, Oldani, Sabina, Lien, Ernst A, Pelosi, Giuseppe, Decensi, Andrea

“…Purpose: In the Anastrozole, Tamoxifen Alone or in Combination trial, the combination arm was inferior to anastrozole alone in terms of disease-free survival…”
Get full text

Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women by DECENSI, Andrea, OMODEI, Umberto, FRANCHI, Massimo, PECORELLI, Sergio, ROBERTSON, Chris, BONANNI, Bernardo, GUERRIERI-GONZAGA, Aliana, RAMAZZOTTO, Francesca, JOHANSSON, Harriet, MORA, Serena, SANDRI, Maria Teresa, CAZZANIGA, Massimiliano

“…The increase in C-reactive protein (CRP) during oral conjugated equine estrogen (CEE) may explain the initial excess of cardiovascular disease observed in…”
Get full text

Breast ductal lavage for biomarker assessment in high risk women: rationale, design and methodology of a randomized phase II clinical trial with nimesulide, simvastatin and placebo by Lazzeroni, Matteo, Guerrieri-Gonzaga, Aliana, Serrano, Davide, Cazzaniga, Massimiliano, Mora, Serena, Casadio, Chiara, Jemos, Costantino, Pizzamiglio, Maria, Cortesi, Laura, Radice, Davide, Bonanni, Bernardo

“…Despite positive results from large phase III clinical trials proved that it is possible to prevent estrogen-responsive breast cancers with selective estrogen…”
Get full text